Literature DB >> 9176542

Measures for detecting systemic bioactivity with inhaled and intranasal corticosteroids.

B J Lipworth1, J R Seckl.   

Abstract

Mesh：

Substances：

Year:  1997        PMID： 9176542      PMCID： PMC1758571          DOI： 10.1136/thx.52.5.476

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  34 in total

1.  Growth and childhood asthma.

Authors:  L Balfour-Lynn
Journal:  Arch Dis Child       Date:  1986-11       Impact factor: 3.791

Review 2.  Pharmacokinetics of inhaled drugs.

Authors:  B J Lipworth
Journal:  Br J Clin Pharmacol       Date:  1996-12       Impact factor: 4.335

3.  Adrenal function in asthma.

Authors:  K Priftis; A D Milner; E Conway; J W Honour
Journal:  Arch Dis Child       Date:  1990-08       Impact factor: 3.791

4.  Reproducibility of the cortisol response to stimulation with a low dose of ACTH(1-24): the effect of basal cortisol levels and comparison of low-dose with high-dose secretory dynamics.

Authors:  S Crowley; P C Hindmarsh; J W Honour; C G Brook
Journal:  J Endocrinol       Date:  1993-01       Impact factor: 4.286

5.  Pharmacokinetics of budesonide in children with asthma.

Authors:  S Pedersen; G Steffensen; I Ekman; M Tönnesson; O Borgå
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

6.  Screening for hypothalamo-pituitary-adrenal axis suppression in asthmatics taking high dose inhaled corticosteroids.

Authors:  P H Brown; G Blundell; A P Greening; G K Crompton
Journal:  Respir Med       Date:  1991-11       Impact factor: 3.415

7.  The use of low doses of ACTH in the investigation of adrenal function in man.

Authors:  S Crowley; P C Hindmarsh; P Holownia; J W Honour; C G Brook
Journal:  J Endocrinol       Date:  1991-09       Impact factor: 4.286

8.  The effect on growth of childhood asthma.

Authors:  A J Martin; L I Landau; P D Phelan
Journal:  Acta Paediatr Scand       Date:  1981-09

9.  Effects of inhaled budesonide on serum markers of bone metabolism in children with asthma.

Authors:  R Sorva; M Turpeinen; K Juntunen-Backman; S L Karonen; A Sorva
Journal:  J Allergy Clin Immunol       Date:  1992-11       Impact factor: 10.793

10.  The effect of long-term glucocorticoid therapy on pituitary-adrenal responses to exogenous corticotropin-releasing hormone.

Authors:  R Schlaghecke; E Kornely; R T Santen; P Ridderskamp
Journal:  N Engl J Med       Date:  1992-01-23       Impact factor: 91.245
View more
  30 in total

1.  The ISOLDE trial. Side effects with inhaled steroids should not be forgotten.

Authors:  B J Lipworth
Journal:  BMJ       Date:  2000-11-25

2.  Cushing's syndrome induced by betamethasone nose drops. In rhinological disease betamethasone should be regarded as systemic corticosteroid.

Authors:  J J Homer; T G Gazis
Journal:  BMJ       Date:  1999-05-15

Review 3.  Safety and tolerability profiles of intranasal antihistamines and intranasal corticosteroids in the treatment of allergic rhinitis.

Authors:  Rami Jean Salib; Peter Hugo Howarth
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

4.  Intranasal delivery--modification of drug metabolism and brain disposition.

Authors:  Yin Cheong Wong; Zhong Zuo
Journal:  Pharm Res       Date:  2010-04-06       Impact factor: 4.200

Review 5.  Deposition and effects of inhaled corticosteroids.

Authors:  Stephen P Newman
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

6.  Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials.

Authors:  J M Weiner; M J Abramson; R M Puy
Journal:  BMJ       Date:  1998-12-12

7.  Comparative lung bioavailability of fluticasone/salmeterol via a breath-actuated spacer and conventional plastic spacers.

Authors:  Arun Nair; Lorna McKinlay; Peter Williamson; Philip Short; Patricia Burns; Brian J Lipworth
Journal:  Eur J Clin Pharmacol       Date:  2011-01-15       Impact factor: 2.953

Review 8.  Systematic review of the dose-response relation of inhaled fluticasone propionate.

Authors:  M Masoli; M Weatherall; S Holt; R Beasley
Journal:  Arch Dis Child       Date:  2004-10       Impact factor: 3.791

9.  Respirable dose delivery of fluticasone propionate from a small valved holding chamber, a compact breath actuated integrated vortex device and a metered dose inhaler.

Authors:  Arun Nair; Daniel Menzies; Martyn Barnes; Patricia Burns; Lesley McFarlane; Brian J Lipworth
Journal:  Br J Clin Pharmacol       Date:  2008-03-13       Impact factor: 4.335

10.  The relationship between fluticasone furoate systemic exposure and cortisol suppression.

Authors:  Ann Allen
Journal:  Clin Pharmacokinet       Date:  2013-10       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.